This is a news story, published by ScienceDaily, that relates primarily to RSV news.
For more vaccine development news, you can click here:
more vaccine development newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
maternal RSV vaccination. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest RSV vaccine timing news, RSV vaccine news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
RSV vaccinationScienceDaily
•
80% Informative
Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus during weeks 32-36 of pregnancy.
Maternal RSV vaccination at least 5 weeks prior to delivery led to the most efficient transfer of maternal antibodies across the placenta to the newborn.
The findings are published in theAmerican Journal of Obstetrics & Gynecology .
VR Score
91
Informative language
98
Neutral language
48
Article tone
formal
Language
English
Language complexity
80
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links